Bank of New York Mellon Corp - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$1,725,000
+3.7%
1,181,899
+0.9%
0.00%
Q4 2016$1,663,000
-15.9%
1,171,453
+3.7%
0.00%
-100.0%
Q3 2016$1,977,000
+1.2%
1,129,645
-1.1%
0.00%0.0%
Q2 2016$1,953,000
-12.6%
1,141,792
+0.7%
0.00%0.0%
Q1 2016$2,234,000
+3.9%
1,134,107
+0.2%
0.00%0.0%
Q4 2015$2,150,000
-1.9%
1,131,385
-1.3%
0.00%0.0%
Q3 2015$2,191,000
-67.0%
1,146,699
-19.9%
0.00%
-50.0%
Q2 2015$6,641,000
+14.3%
1,431,187
+7.6%
0.00%0.0%
Q1 2015$5,812,000
+41.3%
1,329,976
+12.2%
0.00%
+100.0%
Q4 2014$4,112,000
-20.1%
1,185,265
-3.5%
0.00%0.0%
Q3 2014$5,145,000
-65.1%
1,227,825
-51.1%
0.00%
-50.0%
Q2 2014$14,724,000
+86.6%
2,512,380
+100.6%
0.00%0.0%
Q1 2014$7,892,000
+8.2%
1,252,669
+0.4%
0.00%0.0%
Q4 2013$7,296,000
-44.8%
1,247,205
-50.2%
0.00%0.0%
Q3 2013$13,210,000
+41.7%
2,506,660
+107.1%
0.00%
-33.3%
Q2 2013$9,320,0001,210,3680.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 1,281,400$6,753,0003.37%
Perceptive Advisors 5,116,200$26,962,0001.11%
SAMLYN CAPITAL, LLC 2,266,565$11,945,0000.33%
Tradeworx Inc. 132,839$700,0000.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,216,579$6,411,0000.30%
Lyons Wealth Management, LLC. 56,775$299,0000.27%
DIALECTIC CAPITAL MANAGEMENT, LP 125,000$659,0000.15%
Schonfeld Group Holdings LLC 11,400$60,0000.12%
DIALECTIC CAPITAL MANAGEMENT, LP 70,000$369,0000.08%
ELLINGTON MANAGEMENT GROUP LLC 72,000$379,0000.07%
View complete list of ARENA PHARMACEUTICALS INC shareholders